Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 107.67%953K | -85.39%3.3M | -81.72%5.01M | 30.12%-3.39M | 196.48%14.1M | -259.02%-12.43M | 333.75%22.57M | 27.42M | -4.85M | -14.62M |
| Net profit before non-cash adjustment | 24.61%-1.88M | 51.38%-8.11M | 73.50%-2.48M | 95.30%-344K | -34.76%-2.8M | 66.22%-2.49M | -34.78%-16.68M | ---9.36M | ---7.32M | ---2.07M |
| Total adjustment of non-cash items | 5.92%2.31M | -41.28%9.23M | -48.82%3.28M | -83.26%1.56M | -49.35%2.21M | 12.49%2.18M | 134.05%15.72M | --6.42M | --9.3M | --4.36M |
| -Depreciation and amortization | ---- | -18.63%8.66M | ---- | ---- | ---- | ---- | 52.52%10.64M | ---- | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | -105.08%-175K | ---- | ---- | ---- | ---- | 115.32%3.44M | ---- | ---- | ---- |
| -Disposal profit | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Net exchange gains and losses | ---- | --0 | ---- | ---- | ---- | ---- | -18.52%-32K | ---- | ---- | ---- |
| -Other non-cash items | 5.92%2.31M | -55.22%746K | 31.89%-5.2M | -83.26%1.56M | -49.35%2.21M | 12.49%2.18M | -72.54%1.67M | ---7.64M | --9.3M | --4.36M |
| Changes in working capital | 104.32%523K | -90.75%2.18M | -86.14%4.21M | 32.61%-4.6M | 186.89%14.69M | -191.44%-12.12M | -44.61%23.54M | --30.37M | ---6.83M | ---16.91M |
| -Change in receivables | 32,220.00%1.62M | -145.86%-14.27M | -151.25%-15.11M | -53.94%754K | 100.32%79K | -99.96%5K | 983.98%31.12M | --29.48M | --1.64M | ---24.65M |
| -Change in inventory | -36.69%-1.1M | 280.83%20.79M | 3,650.52%32.52M | 70.16%-3.69M | -219.98%-7.23M | 42.45%-804K | -143.11%-11.5M | --867K | ---12.37M | --6.03M |
| -Change in payables | 100.05%6K | -196.67%-3.86M | -13,773.12%-12.72M | -142.63%-1.66M | 1,167.44%21.84M | -1,627.80%-11.32M | -90.88%4M | --93K | --3.9M | --1.72M |
| -Changes in other current assets | ---- | -507.59%-480K | ---- | ---- | ---- | ---- | -115.05%-79K | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 61.28%-757K | 68.65%-1.96M | -626K | 0 | 0 | |||||
| Interest received (cash flow from operating activities) | 0 | -79.53%35K | ||||||||
| Tax refund paid | 102.12%11K | -30.16%-1.15M | -159.75%-2.29M | 2.2M | -539K | -519K | -84.13%-882K | -882K | ||
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 107.44%964K | -92.96%1.39M | -92.02%1.97M | 75.53%-1.19M | 192.80%13.56M | -265.66%-12.95M | 222.04%19.77M | --24.62M | ---4.85M | ---14.62M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | --0 | 60.91%-9.5M | 28.13%-17.47M | --125K | --4.77M | --3.08M | -747.75%-24.31M | ---24.31M | ---- | ---- |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | -105.30%-100K | ---- | ---- | ---- |
| Net investment product transactions | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net changes in other investments | ---- | 288,533.33%17.31M | ---- | ---- | ---- | ---- | -101.35%-6K | ---- | ---- | ---- |
| Investing cash flow | --0 | 131.97%7.81M | 99.33%-163K | --125K | --4.77M | --3.08M | -4,479.92%-24.41M | ---24.41M | ---- | ---- |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 52.62%-723K | 3.12%-3.26M | -102.60%-97K | 99.55%-32K | -725.77%-1.6M | 79.25%-1.53M | 26.58%-3.36M | --3.72M | ---7.09M | ---194K |
| Net common stock issuance | ---- | --0 | --0 | --0 | --0 | --0 | -47.45%16.23M | --1.9M | --14.33M | --0 |
| Increase or decrease of lease financing | -9.25%-1.41M | -20.64%-5.31M | 6.79%-1.22M | 51.75%-1.49M | -15.59%-1.31M | -96.79%-1.29M | 2.85%-4.4M | ---1.31M | ---3.09M | ---1.14M |
| Interest paid (cash flow from financing activities) | 64.75%-92K | 40.49%-776K | 84.89%-144K | 55.84%-155K | ---216K | 25.64%-261K | 35.80%-1.3M | ---953K | ---351K | --0 |
| Net other fund-raising expenses | -87.54%1.62M | 2,885.23%21.5M | ---- | ---- | ---- | --13M | 47.66%-772K | ---- | ---- | ---- |
| Financing cash flow | -106.07%-602K | -211.46%-8.57M | -117.64%-686K | -144.21%-1.68M | -1,113.39%-16.13M | 66.14%9.92M | -62.11%7.69M | --3.89M | --3.8M | ---1.33M |
| Net cash flow | ||||||||||
| Beginning cash position | -91.77%52K | 84.13%-575K | 102.02%143K | 147.84%2.88M | -91.27%678K | 110.48%632K | 62.23%-3.62M | ---7.08M | ---6.03M | --7.76M |
| Current changes in cash | 686.96%362K | -79.44%627K | -72.75%1.12M | -161.80%-2.74M | 113.83%2.21M | -99.67%46K | -14.31%3.05M | --4.1M | ---1.05M | ---15.95M |
| Effect of exchange rate changes | ---- | --0 | ---- | ---- | ---- | ---- | -110.00%-1K | ---- | ---- | ---- |
| End cash Position | -38.94%414K | 109.04%52K | 109.04%52K | 102.02%143K | 135.24%2.88M | -91.27%678K | 90.46%-575K | ---575K | ---7.08M | ---8.18M |
| Free cash flow | 107.44%964K | -78.85%-8.11M | 473.80%1.8M | 78.11%-1.06M | 128.10%4.11M | -265.66%-12.95M | 77.37%-4.53M | --313K | ---4.85M | ---14.62M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.